Literature DB >> 22241216

Antifibrotic and antioxidant effects of N-acetylcysteine in an experimental cholestatic model.

Marina Galicia-Moreno1, Liliana Favari, Pablo Muriel.   

Abstract

OBJECTIVES: Several studies have suggested that oxidative stress may play an important role in the pathogenesis of hepatic injury during cholestasis in rats and humans. The aim of this study was to evaluate the ability of N-acetylcysteine (NAC) to prevent the damage induced by bile duct ligation (BDL) for 28 days in male Wistar rats.
METHODS: NAC was administered daily (300 mg/kg, orally) for 28 days. Alanine aminotransferase was quantified in the serum; lipid peroxidation, glutathione, and catalase activity were measured in the liver. Fibrosis was assessed by measuring the liver hydroxyproline content; transforming growth factor-β (TGF-β), interleukin (IL)-6, and IL-10 were determined in the liver by a western blot and quantified densitometrically.
RESULTS: The induction of cholestatic damage by BDL was associated with an increase in alanine aminotransferase. Oxidative stress was also evaluated; lipid peroxidation increased, whereas the liver glutathione content and catalase activity decreased by BDL. NAC treatment prevented these alterations. Hydroxyproline was increased by chronic BDL, but NAC preserved the normal hydroxyproline levels. Cytokines TGF-β, IL-6, and IL-10 increased after 28 days of BDL. NAC was effectively significant in preventing TGF-β and IL-6 expression and further augmented the IL-10 expression.
CONCLUSION: Our data indicate that in the development to cholestatic liver damage, oxidative stress plays an important role and this in turn leads to fibrosis. This study shows that the beneficial effects of NAC are because of its antioxidant and immunomodulatory properties.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22241216     DOI: 10.1097/MEG.0b013e32834f3123

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  12 in total

1.  Dysregulation of antioxidant responses in patients diagnosed with concomitant Primary Sclerosing Cholangitis/Inflammatory Bowel Disease.

Authors:  Colin T Shearn; David J Orlicky; Dennis R Petersen
Journal:  Exp Mol Pathol       Date:  2017-11-24       Impact factor: 3.362

2.  Resveratrol attenuates both small bowel and liver changes in obstructive jaundice.

Authors:  Volkan Temi; Erdem Okay; Abdullah Güneş; Turgay Simşek; Mustafa Cekmen; Umit Bilgili; Yeşim Gürbüz
Journal:  Balkan Med J       Date:  2014-03-01       Impact factor: 2.021

3.  Glutathione Supplementation Attenuates Oxidative Stress and Improves Vascular Hyporesponsiveness in Experimental Obstructive Jaundice.

Authors:  Jiaying Chen; Feixiang Wu; Yue Long; Weifeng Yu
Journal:  Oxid Med Cell Longev       Date:  2015-06-16       Impact factor: 6.543

4.  Can Chronic Nitric Oxide Inhibition Improve Liver and Renal Dysfunction in Bile Duct Ligated Rats?

Authors:  Mona Fouad Mahmoud; Sara Zakaria; Ahmed Fahmy
Journal:  Adv Pharmacol Sci       Date:  2015-11-25

5.  The Role of e-NOS in Chronic Cholestasis-Induced Liver and Renal Injury in Rats: The Effect of N-Acetyl Cysteine.

Authors:  Yusuf Gunay; Semsi Altaner; Nergiz Ekmen
Journal:  Gastroenterol Res Pract       Date:  2014-11-09       Impact factor: 2.260

6.  Vitamin A supplementation alleviates extrahepatic cholestasis liver injury through Nrf2 activation.

Authors:  Guiyang Wang; Peng Xiu; Fu Li; Cheng Xin; Kewei Li
Journal:  Oxid Med Cell Longev       Date:  2014-07-09       Impact factor: 6.543

Review 7.  Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine.

Authors:  Kívia Queiroz de Andrade; Fabiana Andréa Moura; John Marques dos Santos; Orlando Roberto Pimentel de Araújo; Juliana Célia de Farias Santos; Marília Oliveira Fonseca Goulart
Journal:  Int J Mol Sci       Date:  2015-12-18       Impact factor: 5.923

8.  Downregulation of WNT11 is associated with bladder tissue fibrosis in patients with interstitial cystitis/bladder pain syndrome without Hunner lesion.

Authors:  Daeheon Choi; Ju-Young Han; Jung Hyun Shin; Chae-Min Ryu; Hwan Yeul Yu; Aram Kim; Seungun Lee; Jisun Lim; Dong-Myung Shin; Myung-Soo Choo
Journal:  Sci Rep       Date:  2018-06-28       Impact factor: 4.379

9.  A phase 2 trial of N-Acetylcysteine in Biliary atresia after Kasai portoenterostomy.

Authors:  Mary Elizabeth M Tessier; Benjamin L Shneider; Mary L Brandt; Dana N Cerminara; Sanjiv Harpavat
Journal:  Contemp Clin Trials Commun       Date:  2019-05-02

Review 10.  The Role of Oxidative Stress and Antioxidants in Liver Diseases.

Authors:  Sha Li; Hor-Yue Tan; Ning Wang; Zhang-Jin Zhang; Lixing Lao; Chi-Woon Wong; Yibin Feng
Journal:  Int J Mol Sci       Date:  2015-11-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.